NCT06518512Active, not recruiting
Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD Patients
Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet Age Related Macular Degeneration (AMD) Patients: a Prospective Clinical Evaluation (AVIGA2)
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
The study aims to evaluate the Automated Vision Assessment and Impairment Detection through Gaze Analysis (AVIGA) system in the ability to detect and assess central vision dysfunction in a personalized, adaptive, objective, and automated way through eye gaze tracking in age-related macular degeneration (AMD). We also aim to develop a novel algorithm / scoring methodology for disease activity monitoring over time (delta-change). AVIGA visual risk prediction cut-off scores will be presented together with probabilities of occurrence of prespecified adverse clinical outcome.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 128 (estimated)
- First submitted
- 18 Jul 2024
- Start date
- 18 Apr 2023
- Primary completion date
- Dec 2026
- Lead sponsor
- Tan Tock Seng Hospital
- Diseases
- Macular degeneration
- NCT number
- NCT06518512
What you commit to
- Study type: Observational
- Planned participants: 128
- From 18 Apr 2023 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Any concurrent intraocular condition in the study eye that, in the opinion of the investigator, could either reduce the potential for visual improvement or require medical or surgical intervention during the study
Other illness
- Any history of macular pathology unrelated to AMD affecting vision or contributing to the presence of intraretinal or subretinal fluid in the study eye
- History of idiopathic or autoimmune-associated uveitis in either eye
- Active ocular inflammation or suspected or active ocular or periocular infection in either eye
Other
- Uncontrolled blood pressure, defined as systolic blood pressure \>180 millimeters of mercury (mmHg) and/or diastolic blood pressure \>100 mmHg while a patient is at rest.
- Other protocol-specified exclusion criteria may apply
Who the study is looking for
- Subjects in the age group = 55 years and above.
- Both genders
- Subjects with Wet-AMD
- Ability to comply with the study protocol, in the investigator\'s judgment
- Subjects must be able to understand and provide informed consent. A signed informed consent form must be provided before any study assessments are done.
Age in the registry: 55 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tan Tock Seng Hospital Coordinator of this site? Confirm its status | Singapore | Singapore | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.